The ROE as of September 2024 (TTM) for HilleVax, Inc. (HLVX) is -62.01%

According to HilleVax, Inc.’s latest financial reports and current stock price. The company's current ROE is -62.01%. This represents a change of 287.47% compared to the average of -16.00% of the last 4 quarters.

HilleVax, Inc. (HLVX) Historical ROE (quarterly & annually)

How has HLVX ROE performed in the past?

The mean historical ROE of HilleVax, Inc. over the last ten years is 23.77%. The current -62.01% ROE has changed -360.87% with respect to the historical average. Over the past ten years (40 quarters), HLVX's ROE was at its highest in in the September 2021 quarter at 97.43%. The ROE was at its lowest in in the June 2022 quarter at -31.35%.

HilleVax, Inc. (HLVX) ROE by Quarter and Year

Discovering the peaks and valleys of HilleVax, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

HilleVax, Inc. (HLVX) Average ROE

How has HLVX ROE performed in the past?

The current ROE of HilleVax, Inc. (HLVX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

HilleVax, Inc. (HLVX) ROE vs. Peers

How is HLVX’s ROE compared to its peers?

HilleVax, Inc.’s ROE is greater than PMV Pharmaceuticals, Inc. (-21.96%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than MediciNova, Inc. (-13.37%), greater than Pharvaris N.V. (-36.89%), greater than PepGen Inc. (-62.74%), greater than Molecular Partners AG (-33.08%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), less than Entrada Therapeutics, Inc. (35.16%), greater than Vigil Neuroscience, Inc. (-76.02%), greater than Century Therapeutics, Inc. (-65.37%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than C4 Therapeutics, Inc. (-44.60%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Pardes Biosciences, Inc. (-54.84%), greater than Shattuck Labs, Inc. (-68.65%), less than Champions Oncology, Inc. (323.52%), greater than NewAmsterdam Pharma Company N.V. (-81.09%), greater than Centessa Pharmaceuticals plc (-63.22%), greater than Sutro Biopharma, Inc. (-97.19%), less than Opthea Limited (360.05%),

Build a custom stock screener for HilleVax, Inc. (HLVX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HilleVax, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HilleVax, Inc. (HLVX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HilleVax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.